| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +69.8% |
| Cost of Revenue | $555K | +55.9% |
| Gross Profit | $464K | +90.2% |
| R&D Expense | $1.9M | -4.9% |
| SG&A Expense | $8.3M | +14.6% |
| Operating Income | -$9.7M | -8.3% |
| Interest Expense | $2K | -81.8% |
| Net Income | -$9.7M | -17.3% |
| EPS (Basic) | -$15.50 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | -48.8% |
| Accounts Receivable | $113K | +46.8% |
| Inventory | $853K | -14.8% |
| Current Assets | $6.1M | -42.6% |
| Total Assets | $6.8M | -41.0% |
| Current Liabilities | $1.3M | +40.4% |
| Total Liabilities | $1.5M | +2.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.6M | -10.3% |
| Capital Expenditures | $174K | +74.0% |
| Investing Cash Flow | -$170K | -71.7% |
| Financing Cash Flow | $4.2M | -69.1% |
| Free Cash Flow | -$8.8M | -11.1% |
| -4.9% |
| EPS (Diluted) | -$15.50 | -4.9% |
| Stockholders' Equity |
| $5.3M |
| -47.4% |